Tvardi Therapeutics, Inc. SEC filings TVRD
Tvardi Therapeutics, Inc. has 809 filings in SEC EDGAR's recent list, going back to Dec 6, 2005. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Jul 17, 2026 | — |
| POS AM | Filing | May 8, 2026 | — |
| S-3 | Shelf registration | May 1, 2026 | — |
| S-8 | Employee stock plan registration | Apr 1, 2026 | — |
| 424B3 | Prospectus | Apr 1, 2026 | — |
| 424B3 | Prospectus | Mar 6, 2026 | — |
| 424B3 | Prospectus | Nov 13, 2025 | — |
| S-8 | Employee stock plan registration | Oct 20, 2025 | — |
| S-1/A | Amended registration statement | Oct 20, 2025 | — |
| S-1/A | Amended registration statement | Oct 7, 2025 | — |
| S-1 | Registration statement | May 30, 2025 | — |
| 424B3 | Prospectus | Feb 14, 2025 | — |
| S-4/A | Filing | Feb 14, 2025 | — |
| S-4/A | Form s-4/a | Jan 27, 2025 | — |
| S-4 | Registration for a merger or exchange | Dec 18, 2024 | — |
| 424B5 | Prospectus supplement | Jun 7, 2024 | — |
| S-8 | Employee stock plan registration | Mar 6, 2024 | — |
| S-8 | Employee stock plan registration | Mar 6, 2023 | — |
| S-3/A | Filing | May 9, 2022 | — |
| S-3 | Shelf registration | Mar 1, 2022 | — |
| S-8 | Employee stock plan registration | Mar 1, 2022 | — |
| S-8 | Employee stock plan registration | Mar 1, 2021 | — |
| S-8 | Employee stock plan registration | Feb 28, 2020 | — |
| S-8 | Employee stock plan registration | Nov 20, 2019 | — |
| S-3ASR | Automatic shelf registration | Sep 9, 2019 | — |
| 424B5 | Prospectus supplement | Jul 25, 2019 | — |
| 424B5 | Prospectus supplement | Jul 24, 2019 | — |
| S-8 | Employee stock plan registration | Mar 15, 2019 | — |
| S-3 | Shelf registration | Mar 15, 2019 | — |
| 424B5 | Prospectus supplement | Jul 20, 2018 | — |
| 424B5 | Prospectus supplement | Jul 17, 2018 | — |
| S-8 | Employee stock plan registration | Mar 16, 2018 | — |
| 424B5 | Prospectus supplement | Mar 31, 2017 | — |
| 424B5 | Prospectus supplement | Mar 29, 2017 | — |
| S-3 | Shelf registration | Mar 13, 2017 | — |
| S-8 | Employee stock plan registration | Mar 10, 2017 | — |
| S-8 | Employee stock plan registration | Mar 11, 2016 | — |
| 424B5 | Prospectus supplement | Jul 30, 2015 | — |
| 424B4 | Prospectus | Jul 27, 2015 | — |
| S-3 | Shelf registration | Mar 27, 2015 | — |
| S-8 | Employee stock plan registration | Mar 27, 2015 | — |
| S-8 | Employee stock plan registration | Feb 12, 2014 | — |
| 424B4 | Prospectus | Feb 3, 2014 | — |
| S-1/A | Amended registration statement | Jan 17, 2014 | — |
| S-1/A | Amended registration statement | Dec 31, 2013 | — |
| S-1 | Registration statement | Nov 8, 2013 | — |
Showing 46 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TVRD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Sugar Land, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1346830
- Former names
- Cara Therapeutics, Inc. (until Apr 11, 2025); Cara Therapeutics Inc (until Jul 21, 2010)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.